News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
3,513 Results
Type
Article (412)
Company Profile (1)
Press Release (3100)
Section
Business (1556)
Career Advice (11)
Deals (250)
Drug Delivery (3)
Drug Development (532)
Employer Resources (4)
FDA (51)
Job Trends (147)
News (2154)
Policy (117)
Tag
Academia (8)
Allergies (2)
Alliances (157)
ALS (1)
Alzheimer's disease (13)
Approvals (54)
Artificial intelligence (1)
Bankruptcy (3)
Best Places to Work (122)
Bladder cancer (1)
Brain cancer (1)
Breast cancer (2)
Cancer (31)
Cardiovascular disease (2)
Career advice (11)
CAR-T (1)
CDC (1)
Cell therapy (8)
Cervical cancer (1)
Clinical research (419)
Collaboration (11)
Compensation (16)
Complete response letters (2)
COVID-19 (47)
C-suite (2)
Data (41)
Diabetes (1)
Diagnostics (25)
Diversity, equity & inclusion (1)
Drug pricing (3)
Earnings (1354)
Editorial (1)
Employer resources (3)
Events (474)
Executive appointments (2)
FDA (70)
Funding (9)
Gene editing (1)
Gene therapy (8)
GLP-1 (31)
Government (24)
Guidances (10)
Healthcare (75)
HIV (1)
IgA nephropathy (3)
Immunology and inflammation (3)
Immuno-oncology (1)
Indications (1)
Infectious disease (49)
Inflation Reduction Act (1)
Interviews (1)
IPO (174)
IRA (1)
Job creations (29)
Job search strategy (11)
Labor market (2)
Layoffs (10)
Legal (22)
Liver cancer (2)
Lung cancer (11)
Lymphoma (2)
Management (1)
Manufacturing (3)
MASH (20)
Medical device (22)
Medtech (22)
Mergers & acquisitions (84)
Metabolic disorders (24)
Multiple sclerosis (1)
NASH (2)
Neurodegenerative disease (1)
Neuroscience (18)
NextGen: Class of 2026 (31)
Non-profit (5)
Obesity (4)
Opinion (4)
Ovarian cancer (1)
Pain (2)
Partnered (1)
Peanut (1)
People (119)
Phase 1 (131)
Phase 2 (204)
Phase 3 (193)
Pipeline (72)
Policy (2)
Postmarket research (3)
Preclinical (29)
Press Release (1)
Prostate cancer (1)
Psychedelics (2)
Radiopharmaceuticals (5)
Rare diseases (3)
Real estate (14)
Recruiting (1)
Regulatory (91)
Reports (1)
Research institute (9)
Schizophrenia (1)
Series A (2)
Series B (1)
Special edition (1)
Spinal muscular atrophy (1)
Startups (20)
The Weekly (2)
Vaccines (13)
Venture capital (2)
Weight loss (1)
Women's health (1)
Date
Today (1)
Last 7 days (3)
Last 30 days (13)
Last 365 days (219)
2026 (16)
2025 (221)
2024 (327)
2023 (339)
2022 (426)
2021 (358)
2020 (272)
2019 (262)
2018 (138)
2017 (166)
2016 (159)
2015 (171)
2014 (82)
2013 (78)
2012 (88)
2011 (79)
2010 (90)
Location
Africa (12)
Asia (245)
Australia (25)
California (95)
Canada (7)
China (10)
Colorado (1)
Connecticut (4)
Delaware (14)
Europe (997)
Florida (16)
Georgia (1)
Illinois (1)
India (2)
Indiana (2)
Japan (2)
Kansas (1)
Louisiana (1)
Maryland (9)
Massachusetts (42)
Michigan (1)
Minnesota (1)
Montana (1)
Nevada (1)
New Hampshire (2)
New Jersey (14)
New York (22)
North Carolina (11)
Northern California (73)
Ohio (1)
Oregon (1)
Pennsylvania (21)
South America (10)
Southern California (20)
Tennessee (1)
Texas (9)
United States (265)
Washington D.C. (1)
Washington State (8)
3,513 Results for "89bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
‘We’re Not Done’: Roche Plans To Sustain Dealmaking Pace After 89bio
Roche has already signed several high-ticket deals this year, including the $3.5 billion acquisition of 89bio and Genentech’s $2.1 billion molecular glue pact with Orionis Biosciences.
October 23, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
How Akero’s MASH Success Drove Roche’s $3.5B Takeout of 89bio
Regulatory documents show how 89bio’s board pushed Roche hard for a deal valued at $20 per share in upfront and milestone payments.
October 2, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
Roche purchases shares in tender offer for 89bio, Inc
October 30, 2025
·
7 min read
Press Releases
89bio, Inc. Announces Agreement to be Acquired by Roche
September 18, 2025
·
9 min read
Press Releases
89bio to Participate in Upcoming September 2025 Investor Conferences
August 29, 2025
·
1 min read
Mergers & acquisitions
Roche Makes Major MASH Move With $3.5B 89bio Buy
The star of the acquisition, which includes a contingent value right of $6 per share, is pegozafermin, an FGF21 analog in late-stage development for metabolic dysfunction-associated steatohepatitis.
September 18, 2025
·
2 min read
·
Tristan Manalac
Press Releases
89bio Reports Second Quarter 2025 Financial Results and Corporate Updates
August 8, 2025
·
8 min read
Press Releases
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 5, 2025
September 8, 2025
·
1 min read
Press Releases
89bio to Participate in Upcoming May 2025 Investor Conferences
May 7, 2025
·
1 min read
Press Releases
Roche enters into a definitive merger agreement to acquire 89bio, and its phase 3 FGF21 analog for the therapy of moderate to severe MASH
September 18, 2025
·
13 min read
1 of 352
Next
